12:15 EST Arrowhead (ARWR) trading resumes
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARWR:
- Arrowhead announces FDA approval of Redemplo for FCS
- Arrowhead’s plozasiran approved by FDA in familial chylomicronemia syndrome
- Arrowhead trading halted, news pending
- REGN, GMAB, ARWR: Which Healthcare Stock Is Best Buy Ahead of U.S. Drug Approvals This Nov?
- Arrowhead price target raised to $45 from $29 at Morgan Stanley